BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion

  June 29, 2026

   · 

  6 min read
• Press Releases

  Zymeworks to Acquire Theravance Biopharma, Inc.

  June 29, 2026

   · 

  17 min read
• Press Releases

  Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer

  June 29, 2026

   · 

  6 min read
• 

  Approvals

  Viridian debuts on market with FDA greenlight for thyroid eye disease drug

  Viridian Therapeutics’ Lumvoa is the first FDA-approved treatment for thyroid eye disease that includes data for both active and chronic forms of the illness.

  June 29, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Rare diseases

  BridgeBio’s achondroplasia pill shows ‘compelling’ growth and body proportionality benefit

  BridgeBio Pharma plans to file for approval in the third quarter. If granted, the oral drug could present a “highly differentiated” option over current achondroplasia therapies, according to Jefferies.

  June 29, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  The Top 10 Hair Transplant Clinics in Turkey, Ranked by Clinical Standards

  June 29, 2026

   · 

  1 min read
• Press Releases

  Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

  June 29, 2026

   · 

  14 min read
• Press Releases

  Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

  June 29, 2026

   · 

  13 min read
• Press Releases

  United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion

  June 29, 2026

   · 

  8 min read
• Press Releases

  Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV

  June 29, 2026

   · 

  12 min read